Athena Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$274K Hold
1,027
0.14% 124
2025
Q4
$258K Hold
1,027
0.13% 130
2025
Q3
$295K Sell
1,027
-4
-0.4% -$1.07K 0.15% 124
2025
Q2
$271K Hold
1,031
0.15% 129
2025
Q1
$240K Sell
1,031
-6
-0.6% -$1.46K 0.15% 130
2024
Q4
$238K Sell
1,037
-7
-0.7% -$1.61K 0.14% 134
2024
Q3
$233K Buy
1,044
+4
+0.4% +$879 0.13% 138
2024
Q2
$212K Buy
1,040
+48
+5% +$9.76K 0.13% 142
2024
Q1
$217K Buy
992
+40
+4% +$8.81K 0.13% 140
2023
Q4
$216K Buy
+952
New +$200K 0.14% 135

Other funds holding LH

Athena Investment Management's LH Position: Q1 2026 in Review

Athena Investment Management held its Labcorp (LH) position steady in Q1 2026 at 1,027 shares worth $274K. The position accounts for 0.14% of the portfolio, ranked #124.

Athena Investment Management first reported a position in LH in Q4 2023 and has held it in 10 quarters since. The position peaked at $295K in Q3 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Athena Investment Management held 1,027 shares of Labcorp worth $274K as of Q1 2026.
  • Athena Investment Management left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up 0.14% of Athena Investment Management's portfolio in Q1 2026, its #124 holding.
  • Athena Investment Management first reported a position in Labcorp in Q4 2023 and has held it in 10 quarters since.
  • Athena Investment Management's Labcorp position peaked at $295K in Q3 2025.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Athena Investment Management's 13F filing for Q1 2026, filed 12 May 2026.